Efficacy and safety of lenalidomide for refractory cutaneous lupus erythematosus

INTRODUCTION: Cutaneous lupus erythematosus (CLE) is a chronic disease characterized by disfigurement and a relapsing course. Thalidomide has proven its efficacy in refractory cutaneous lupus disease, although it is not exempt from significant side effects and frequent relapses after withdrawal. New...

Descripción completa

Detalles Bibliográficos
Autores principales: Cortés-Hernández, Josefina, Ávila, Gabriela, Vilardell-Tarrés, Miquel, Ordi-Ros, Josep
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3674591/
https://www.ncbi.nlm.nih.gov/pubmed/23217273
http://dx.doi.org/10.1186/ar4111

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3674591/
https://www.ncbi.nlm.nih.gov/pubmed/23217273
http://dx.doi.org/10.1186/ar4111

Ejemplares similares